[1. Infectious Diseases Society of America. Statement of the IDSA concerning Bioshield II: Responding to an everchanging threat’. Alexandria, VA: IDSA; 2004.]Search in Google Scholar
[2. Sun QY, Zhang WN, Xu JM, Cao YB, Wu QY, Zhang DZ, Liu CM, Yu SC, Jiang YY. Synthesis and evaluation of novel 1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-[(4- substitutedphenyl)-piperazin-1-yl]-propan-2-ols as antifungal agents. Eur J Med Chem 2007;42:1151-7. doi: 10.1016/j.ejmech.2006.11.00310.1016/j.ejmech.2006.11.003]Search in Google Scholar
[3. Hilley Vensel TD. Fluconazole: a valuable fungistatic. Primary Car Update for OB/GYNS 2002;9:181-3. doi: 10.1016/S1068-607X(02)00115-410.1016/S1068-607X(02)00115-4]Search in Google Scholar
[4. Loğoğlu E, Arslan S, Öktemer A. In vitro biological activity studies of thioethoxy- and thiophyenoxyhalobenzene derivatives. Heterocycl Comm 2006;12:219-24. doi: 10.1515/HC.2006.12.3-4.21910.1515/HC.2006.12.3-4.219]Search in Google Scholar
[5. Süloğlu AK, Karacaoğlu E, Koçkaya EA, Selmanoğlu G, Loğoğlu E. Cytotoxic effects of a novel thialo benzene derivative 2,4-dithiophenoxy-1-Iodo-4-bromo benzene (C18H12S2IB) in L929 cells. Int J Toxicol 2014;33:319-24. doi: 10.1177/109158181453043710.1177/1091581814530437]Search in Google Scholar
[6. Food and Drug Administration (FDA). DIFLUCAN® (Fluconazole Tablets) (Fluconazole for Oral Suspension) [displayed 2 March 2015]. Available at http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019949s060,020090s044lbl.pdf]Search in Google Scholar
[7. Park K, Williams DP, Naisbitt DJ, Kitteringham NR, Pirmohamed M. Investigation of toxic metabolites during drug development. Toxicol Appl Pharmacol 2005;207(Suppl 2):425-34. PMID: 1599669910.1016/j.taap.2005.02.029]Search in Google Scholar
[8. Joly V, Bolard J, Yeni P. In vitro models for studying toxicity of antifungal agents. Antimicrob Agents Chemother 1992;36:1799-804. PMC 19218910.1128/AAC.36.9.1799]Search in Google Scholar
[9. National Research Council. Guide for the Care and Use of Laboratory Animals. Eighth edition, 2011 [displayed 13 February 2015]. Available at http://grants.nih.gov/grants/olaw/Guide-for-the-care-and-use-of-laboratory-animals.pdf]Search in Google Scholar
[10. Pappas PG, Rex JH, Sobel JD, Filler SG, Dismukes WE, Walsh TJ, Edwards JE. Guidelines for treatment of Candidiasis. Clin Infect Dis 2004;38:161-89. doi: 10.1086/38079610.1086/380796]Search in Google Scholar
[11. Kılıç A, Akay MT. A three generation study with genetically modified Bt corn in rats: Biochemical and histopathological investigation. Food Chem Toxicol 2008;46:1164-70. doi: 10.1016/j.fct.2007.11.01610.1016/j.fct.2007.11.016]Search in Google Scholar
[12. Babu PP, Yoshida Y, Su M, Segura M, Kawamura S, Yasui N. Immunohistochemical expression of Bcl-2, Bax and cytochrome c following focal cerebral ischemia and effect of hypothermia in rat. Neurosci Lett 2000;291:196-200. PMID: 1098464010.1016/S0304-3940(00)01404-X]Search in Google Scholar
[13. Koçkaya EA, Kılıç Süloğlu A, Karacaoğlu E, Selmanoğlu G. Vinclozolin Exposure throughout pregnancy and its developmental toxicity. Toxicol Res 2014;3:375-83. doi: 10.1039/C4TX00037D10.1039/C4TX00037D]Search in Google Scholar
[14. Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76:215-28. doi: 10.1124/mol.109.05670510.1124/mol.109.056705271311819483103]Search in Google Scholar
[15. Sellers RS, Morton D, Michael B, Roome N, Johnson J.K, Yano BL, Perry R, Schafer K. Society of Toxicologic Pathology Position Paper: Organ weight recomendations for toxicology studies. Toxicol Pathol 2007;35:751-5. PMID: 1784935810.1080/0192623070159530017849358]Search in Google Scholar
[16. Fortoul TI, Piñón-Zarate G, Diaz-Bech ME, González- Villalva A, Mussali-Galante P, Rodriguez-Lara V, Colin- Barenque L, Martinez-Pedraza M, Montaño LF. Spleen and bone marrow megakaryocytes as targets as targets for inhaled vanadium. Histol Histopathol 2008;23:1321-6. PMID: 18785114]Search in Google Scholar
[17. Benko I, Hernadi F, Megyeri A, Kiss A, Somogyi G, Tegyey Z, Kraicsovits F, Kovács P. Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro. J Antimicrob Chemother 1999;43:675-81. doi: 10.1093/ jac/43.5.67510.1093/jac/43.5.67510382889]Search in Google Scholar
[18. Feng L, Xia Y, Yoshimura T, Wilson CB. Modulation of neutrophil influx in glomerulonephritis in the rat with antimacrophage inflammatory protein-2 (MIP-2) antibody. J Clin Invest 1995;95:1009-17. doi: 10.1172/JCI11774510.1172/JCI1177454414347883948]Search in Google Scholar
[19. González-Flecha B, Cutrin JC, Boveris A. Time course and mechanism of oxidative stress and tissue damage in rat liver subjected to in vivo ischemia-reperfusion. Clin Invest 1993;91:456-64. doi: 10.1172/JCI11622310.1172/JCI1162232879558432855]Search in Google Scholar
[20. Miller TJ, Knapton A, Adeyemo O, Noory L, Weaver J, Hanig JP. Cytochrome c: a non-invasive biomarker of druginduced liver injury. J Appl Toxicol 2008;28:815-28. doi: 10.1002/jat.134710.1002/jat.134718418843]Search in Google Scholar